Praxis Precision Medicines (PRAX) Net Cash Flow Growth (1y) (2020 - 2026)
Praxis Precision Medicines (PRAX) Net Cash Flow Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,899.61 Bn | 65,899.33 Bn | - | -88.82% |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.67 Bn | 466.88 Bn | 1.35 Bn | 301.06% |
| 5 | Vertex Pharmaceuticals | 122.32 Bn | 115.07 Bn | 2.59 Bn | 453.08% |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.29 Bn | 3.31 Bn | -125.22% |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | - |
| 8 | Argenx Se | 55.93 Bn | 50.74 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.55 Bn | 34.54 Bn | 959.66 Mn | 53.46% |
| 10 | Praxis Precision Medicines | 9.30 Bn | 8.52 Bn | - | 459.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 459.41% |
| Dec 31, 2025 | 344.72% |
| Sep 30, 2025 | -133.56% |
| Jun 30, 2025 | -19.23% |
| Mar 31, 2025 | -170.47% |
| Dec 31, 2024 | 336.17% |
| Sep 30, 2024 | 201.24% |
| Jun 30, 2024 | -115.73% |
| Mar 31, 2024 | 267.67% |
| Dec 31, 2023 | -2,298.18% |
| Sep 30, 2023 | -462.68% |
| Jun 30, 2023 | 299.23% |
| Mar 31, 2023 | 131.28% |
| Dec 31, 2022 | 96.94% |
| Sep 30, 2022 | 162.75% |
| Jun 30, 2022 | -148.32% |
| Mar 31, 2022 | 62.86% |
| Dec 31, 2021 | -114.83% |
| Sep 30, 2021 | -110.73% |
| Jun 30, 2021 | 234.34% |